Blog Category Archive for biotech news

Disease-In-A-Dish: Leveraging in vitro Human Models to Advance Drug Discovery

Disease-In-A-Dish: Leveraging in vitro Human Models to Advance Drug Discovery

Treatment of diseases, especially rare diseases, is very complex due to specific changes in the genetic makeup of the individual patient. As such, a more personalized approach to the generation of therapeutics is gaining greater traction not only with medical personnel, but also with the patient.

The term “personalized medicine” relates to the..

Read More
Teaming Up to Drive Drug Discovery for Rare Disease Patients: Rationale for Nonprofit Patient Foundations and Pharma/Biotech to Collaborate

Teaming Up to Drive Drug Discovery for Rare Disease Patients: Rationale for Nonprofit Patient Foundations and Pharma/Biotech to Collaborate

For many years now, I have been a staunch advocate for non-profit patient foundations and pharmaceutical companies to work together to advance drug discovery efforts that support the objectives of both organizations. Along these lines, I have worked to forge relationships between these types of disparate non-profit patient organizations and the..

Read More
Strategic Outsourcing Supports Pharma’s Focus on Internal Pipelines

Strategic Outsourcing Supports Pharma’s Focus on Internal Pipelines

Recent developments and headlines such as “Lilly's CEO keeps faith in the pipeline as biotech gets 'too expensive'” and “Leery of new deals, Roche spotlights its late-stage pipeline standoutssuggest that more drug companies are relying more on internal pipelines than M&A to remain competitive.   Given how many pharma companies have downsized..

Read More
Can Small Molecule-Reprogramming of Fibroblasts Create Better Drugs or Be Used to Treat Human Neuronal Disorders?

Can Small Molecule-Reprogramming of Fibroblasts Create Better Drugs or Be Used to Treat Human Neuronal Disorders?

A recent move in compound screening dictates the use more biologically relevant cells for drug discovery experiments, but as researchers know, it can be a challenge to obtain enough primary cells. Stem cells have been used to generate biologically relevant cells, but the process is time consuming and expensive.

Read More